Mesothelin protects cancer cells from TNF-α-induced apoptosis by rapidly stimulating Akt phosphorylation under PI3K activation, inhibiting the expression of pro-apoptotic factors, such as Bad and Bax, and promoting the expression of anti-apoptotic genes, such as Bcl-2 and Mcl-1 [35]. The gene discussed is MSLN; the disease is cancer.